Academic article

• Andersen, Thomas; Ueland, Thor; Aukrust, Pål et al. (2023). Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin. (external link)
• Andersen, Thomas; Ueland, Thor; Aukrust, Pål et al. (2022). Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes.. (external link)
• Kontny, Frederic; Andersen, Thomas; Ueland, Thor et al. (2019). Pentraxin-3 vs C-reactive Protein and Other Prognostic Biomarkers in Acute Coronary Syndrome: A Substudy of the Platelet Inhibition and Patients Outcomes (PLATO) Trial.. (external link)
• Andersen, Thomas; Ueland, Thor; Ghukasyan Lakic, Tatevik et al. (2019). C-X-C ligand 16 is an independent predictor of cardiovascular death and morbidity in acute coronary syndromes. (external link)

Poster

• Andersen, Thomas; Nilsen, Dennis W.T.; Grundt, Magnea Heidi Jonsdottir et al. (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A9149. The novel Wnt-Pathway inhibitor podogan is not associated with all-cause mortality or cardiovascular outcome in patients admitted with suspected acute coronary syndrome. . (external link)
• Andersen, Thomas; Nilsen, Dennis W.T.; Grundt, Magnea Heidi Jonsdottir et al. (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A12013. Procollagen type-1 N-terminal propeptide, a collagen synthesis biomarker, is associated with adverse clinical outcome in patients with nsuspected acute coronary syndrome. . (external link)

See a complete overview of publications in Cristin.